Idorsia submits a new drug application to the FDA By Reuters

Idorsia submits a new drug application to the FDA ZURICH (Reuters) - Swiss biotech company Idorsia has submitted a new application for approval of the drug aprocitentan to the U.S. Food and Drug Administration. Aprocitentan is intended to be used in the treatment of patients with…#idorsia #aprocitentan #fda
Source: Reuters: Health - Category: Consumer Health News Source Type: news